Immunogenicity assay of the Leishmune(®) vaccine against canine visceral leishmaniasis in Brazil

Leishmune(®) is the industrialized version of the FML-saponin vaccine which has been shown to develop 92–95% protection in vaccinated dogs and 76–80% vaccine efficacy against field canine visceral leishmaniasis (CVL) in Brazil. Leishmune(®) has been proven to be safe and tolerable and a transmission...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Vaccine
Auteurs principaux: Borja-Cabrera, G.P., Santos, F.N., Bauer, F.S., Parra, L.E., Menz, I., Morgado, A.A., Soares, I.S., Batista, L.M.M., Palatnik-de-Sousa, C.B.
Format: Artigo
Langue:Inglês
Publié: Elsevier Ltd. 2008
Sujets:
Short Communication
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7173152/
https://ncbi.nlm.nih.gov/pubmed/18675868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2008.07.029
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires